Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Sackett (1979)
Bias in analytic research.Journal of chronic diseases, 32 1-2
E. Salzman, G. Davies (1980)
Prophylaxis of Venous Thromboembolism: Analysis of Cost EffectivenessAnnals of Surgery, 191
M. Weinstein, W. Stason (1977)
Foundations of cost-effectiveness analysis for health and medical practices.The New England journal of medicine, 296 13
R. Hull, T. Delmore, C. Carter, J. Hirsh, E. Genton, M. Gent, G. Turpie, D. McLaughlin (1982)
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.The New England journal of medicine, 306 4
L. Poller (1971)
THE BRITISH NATIONAL THROMBOPLASTINBritish Journal of Haematology, 20
J. Hall, R. Pauli, K. Wilson (1980)
Maternal and fetal sequelae of anticoagulation during pregnancy.The American journal of medicine, 68 1
R. Hull, T. Delmore, E. Genton, J. Hirsh, M. Gent, D. Sackett, D. Mcloughlin, P. Armstrong (1979)
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.The New England journal of medicine, 301 16
R. Hull, J. Hirsh, R. Jay, C. Carter, C. England, M. Gent, A. Turpie, D. Mcloughlin, Dodd Pe, Michael Thomas, G. Raskob, P. Ockelford (1982)
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.The New England journal of medicine, 307 27
P. Lietman, J. Pettifor, R. Benson (1975)
Congenital malformations associated with the administration of oral anticoagulants during pregnancy.The Journal of pediatrics, 86 3
R. Hull, J. Hirsh, D. Sackett, G. Stoddart (1981)
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis.The New England journal of medicine, 304 26
Recent data from randomized trials have provided a clear understanding of the effectiveness and safety of differing long-term anticoagulant therapies for proximal vein thrombosis. An issue that has not been addressed is their cost-effectiveness. We have performed a cost-effectiveness analysis to rank alternative approaches for long-term therapy. Less intense oral anticoagulant therapy using warfarin sodium is the most cost-effective approach and is preferred in the majority of patients. (JAMA 1984;252:235-239)
JAMA – American Medical Association
Published: Jul 13, 1984
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.